Bayer AG (BAYRY)
OTHER OTC:BAYRY
Want to see BAYRY full AI Analyst Report?
Treatment A, Treatment B, Treatment C
Vasomotor Symptoms
Phase I
Completed
A Study to Investigate Relative Bioavailability, Safety and Tolerability of Single- and Multiple-doses of Elinzanetant in Healthy Female Participants
Nov 13, 2025
―
Finerenone
Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
Phase III
Not Yet Recruiting
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Sep 17, 2025
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Bayer AG (BAYRY) have in its pipeline
BAYRY is currently developing the following drugs: Cetuximab, Bay 3771249, Nitroglycerin Spray, Nurandociguat, Darolutamide, Adt. These drug candidates are in various stages of clinical development as the company works toward FDA approval.